Earning Preview: Procter & Gamble This Quarter’s Revenue Is Expected To Increase By 2.18%, And Institutional Views Are Bullish
Earnings Agent08:05
Abstract
Procter & Gamble will release its quarterly results on April 24, 2026 Pre-Market; consensus points to modest year-over-year growth in revenue and adjusted EPS alongside stable operating performance, with investors watching margin resilience and input-cost trends into the print.
Market Forecast
Based on the latest projections, Procter & Gamble’s current quarter revenue is estimated at 20.54 billion US dollars, implying a 2.18% year-over-year increase, while adjusted EPS is forecast at 1.56, up 2.20% year-over-year; EBIT is estimated at 4.70 billion US dollars, up 0.15% year-over-year. Forecasts for gross profit margin, net profit, and net margin are not disclosed in the available projections.
The main business remains centered on household and personal categories with pricing and productivity expected to support stable performance across core franchises. The most promising segment is expected to be supported by premium mix and innovation, with Fabric and Home Care revenue at 7.69 billion US dollars in the last quarter; year-over-year growth by segment was not disclosed.
Last Quarter Review
Procter & Gamble reported revenue of 22.21 billion US dollars in the prior quarter, a gross profit margin of 52.03%, GAAP net profit attributable to shareholders of 4.32 billion US dollars, a net profit margin of 19.45%, and adjusted EPS of 1.88, with revenue up 1.49% year-over-year and adjusted EPS flat year-over-year. Net profit decreased sequentially by 9.07%, reflecting normal quarterly variability alongside cost and mix dynamics. By business, Fabric and Home Care contributed 7.69 billion US dollars, Baby, Feminine & Family Care 5.12 billion US dollars, Beauty 4.04 billion US dollars, Health Care 3.41 billion US dollars, Grooming 1.79 billion US dollars, and Corporate/Other 160.00 million US dollars; segment-level year-over-year changes were not disclosed.
A key financial highlight from the quarter was the combination of strong gross margin at 52.03% and disciplined operating cost control that supported profitability even as revenue modestly trailed projections. Another focal point in the business mix was the continued scale of Fabric and Home Care, which remained the largest revenue contributor at 7.69 billion US dollars, underscoring the importance of core brands and pricing architecture; year-over-year growth by segment was not disclosed.
Current Quarter Outlook
Main business: Fabric and Home Care
Fabric and Home Care is the company’s largest revenue pool and is expected to continue anchoring aggregate performance in the current quarter. The category’s last-quarter revenue of 7.69 billion US dollars provides a high base from which management’s pricing, promotion discipline, and productivity programs can sustain mid-cycle momentum. Into this print, the most important variables are the net effect of price carryover versus elasticities in laundry and home cleaning, and any mix shifts toward higher-value formats that support margin per unit.
On costs, resin and other oil-derived inputs are a swing factor for packaging and some product components; sensitivity to resin has been cited across the household and personal care space. While spot energy and feedstock prints have been volatile, the company’s scale purchasing and ongoing productivity initiatives can help absorb incremental pressure, especially if premium mix holds. In distribution, steady shelf placements and replenishment patterns should support sell-in, and management’s focus on supply chain agility may limit stock outs or heavy promotional discounting that could pressure margins.
Looking through the quarter, the blend of carryover pricing, productivity, and possible easing in certain non-resin commodities could leave gross margin stable versus last quarter’s 52.03% baseline. Volume recovery tends to lag price actions in these categories, so a balanced outcome—slight volume improvement with stable price/mix—would be consistent with the modest revenue and EPS growth embedded in current estimates. Given its outsized weight in group revenue and profit, execution in Fabric and Home Care will remain the dominant driver of consolidated results this quarter.
Most promising business: Beauty
Beauty generated 4.04 billion US dollars in revenue in the prior quarter and is positioned to benefit from premiumization and sustained brand support. The category’s earnings sensitivity is often more closely tied to mix and innovation cadence than to commodity inputs, which can make its margin structure relatively resilient if product upgrades and channel strategies perform to plan. In the near term, marketing investments around key franchises are expected to emphasize premium segments, which, if sustained, can lift average selling prices and unit economics.
The quarter’s progression is likely to reflect incremental benefits from portfolio rationalization and targeted launches, with international markets contributing a meaningful portion of category sales. Currency translation remains a variable for reported growth, but the forecasted 2.18% revenue growth at the total-company level suggests topline headroom even with mixed FX. On balance, Beauty offers an earnings mix supportive of consolidated margin stability given its relative insulation from certain packaging-sensitive inputs, though execution on product availability and the timing of promotional windows will matter for sell-through.
Given the company’s overall EPS projection of 1.56, up 2.20% year-over-year, Beauty’s contribution is likely to skew positive for margin quality if premium mix holds. Any upside from lower-than-expected promotion intensity or better-than-expected reorder rates would help offset potential cost headwinds from other categories. The broader takeaway: Beauty provides a constructive backdrop for consolidated profitability while maintaining optionality for selective reinvestment in growth initiatives.
Key stock-price drivers this quarter
The first driver is margin trajectory relative to the prior quarter’s 52.03% gross margin and 19.45% net margin. With revenue forecast at 20.54 billion US dollars and EPS at 1.56, the market is implicitly assuming that gross-to-operating margin holds near recent levels, supported by price/mix and productivity. Any deviation—either from input-cost surprises or higher promotion spend—will have a visible impact on EPS conversion, which is closely watched in this print.
The second driver is commodity and packaging costs, particularly resin. Commentary across the household and personal space has highlighted resin cost uncertainty tied to energy and geopolitical factors; even if spikes prove temporary, the stickiness of certain input prices could compress margins if not fully offset by productivity or price/mix. The company’s scale and multi-quarter buy programs mitigate some volatility, but investors will focus on management’s cost outlook and the cadence of productivity savings versus inflation.
The third driver is capital returns and cash discipline. The recent announcement to raise the quarterly dividend to 1.0885 per share underscores ongoing capital return commitment into the quarter. While not a direct input to the income statement, sustained dividend growth and the company’s cash generation profile can influence sentiment and valuation resilience, especially in a quarter where EPS growth is modest. Any update on buyback pacing or cash prioritization between reinvestment and shareholder returns may also shape post-earnings reaction.
Analyst Opinions
Across the review period, published views on Procter & Gamble skew bullish when classified strictly as bullish (Buy/Outperform/Overweight) versus bearish (Sell/Underperform), with bullish opinions representing 100% of the Buy/Sell cohort and no major Sell or Underperform calls surfaced. Notable bullish reiterations include RBC maintaining an Outperform rating with a 167.00 US dollars price target, UBS maintaining a Buy while adjusting the target to 166.00 US dollars, Wells Fargo maintaining an Overweight rating with targets around 177.00 US dollars, and Citi maintaining a Buy with a target of 181.00 US dollars. These institutions emphasize the durability of cash generation, the support from price/mix and productivity, and a balanced cost outlook despite packaging and input volatility.
The core of the bullish thesis heading into April 24, 2026 is that the projected revenue growth of 2.18% year-over-year and forecast adjusted EPS of 1.56 (+2.20% year-over-year) remain achievable under conservative assumptions, given the company’s execution on portfolio focus and productivity. Analysts point to the combination of pricing discipline and brand investment as drivers for stable gross margin, even if resin and other oil-linked costs remain a headwind. Where models vary is in their translation of cost scenarios into operating leverage, but the consensus view remains that EBIT of roughly 4.70 billion US dollars (+0.15% year-over-year) is consistent with recent run rates.
In addition, bullish views highlight that the company’s dividend increase to 1.0885 per share signals confidence in cash generation through the quarter and beyond. That signal matters in a setup where EPS growth is incremental; it suggests that cash conversion of earnings remains robust, an important consideration for valuation support. Within category dynamics, bullish institutions expect the mainstay Fabric and Home Care to provide steady contribution while Beauty and Health-adjacent categories offer favorable mix; this supports the notion that consolidated margin can hold near the prior quarter’s level, aligning with consensus EPS.
On the risk side, bullish analysts acknowledge that resin and packaging costs could trend higher and FX could dilute reported growth, but they argue these are manageable within the framework of price carryover and cost savings. The absence of Sell/Underperform ratings in the observed period reinforces the view that, while upside may be incremental, downside scenarios are cushioned by the company’s pricing power, productivity, and cash allocation discipline. In short, among institutions providing explicit Buy/Outperform/Overweight stances, the prevailing outlook into the print is that projections for revenue and EPS carry balanced-to-positive risk, with margin commentary likely determining whether shares consolidate or re-rate post-release.Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
